Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1998 1
1999 2
2001 2
2002 1
2003 3
2004 1
2009 8
2010 9
2011 10
2012 6
2013 6
2014 10
2015 6
2016 7
2017 10
2018 15
2019 8
2020 8
2021 5
2022 3
2023 9
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

116 results

Results by year

Filters applied: . Clear all
Page 1
Randomized, open-label, phase II, biomarker study of immune-mediated mechanism of action of neoadjuvant subcutaneous trastuzumab in patients with locally advanced, inflammatory, or early HER2-positive breast cancer-Immun-HER trial (GOIRC-01-2016).
Pellegrino B, Tommasi C, Serra O, Gori S, Cretella E, Ambroggi M, Frassoldati A, Bisagni G, Casarini C, Bria E, Carbognin L, Fiorio E, Mura A, Zamagni C, Gianni L, Zambelli A, Montemurro F, Tognetto M, Todeschini R, Missale G, Campanini N, Silini EM, Maglietta G, Musolino A. Pellegrino B, et al. Among authors: silini em. J Immunother Cancer. 2023 Nov 28;11(11):e007667. doi: 10.1136/jitc-2023-007667. J Immunother Cancer. 2023. PMID: 38016718 Free PMC article. Clinical Trial.
Resistance to osimertinib in advanced EGFR-mutated NSCLC: a prospective study of molecular genotyping on tissue and liquid biopsies.
Leonetti A, Verzè M, Minari R, Perrone F, Gnetti L, Bordi P, Pluchino M, Nizzoli R, Azzoni C, Bottarelli L, Lagrasta CAM, Mazzaschi G, Buti S, Gasparro D, Cosenza A, Ferri L, Majori M, De Filippo M, Ampollini L, La Monica S, Alfieri R, Silini EM, Tiseo M. Leonetti A, et al. Among authors: silini em. Br J Cancer. 2024 Jan;130(1):135-142. doi: 10.1038/s41416-023-02475-9. Epub 2023 Nov 8. Br J Cancer. 2024. PMID: 37938348
Diagnostic Criteria of Pediatric Intestinal Myopathies.
Lombardi L, Bruder E, Pio L, Nozza P, Thai E, Lerone M, Del Rossi C, Mattioli G, Silini EM, Paraboschi I, Martucciello G. Lombardi L, et al. Among authors: silini em. J Pediatr Gastroenterol Nutr. 2018 Mar;66(3):383-386. doi: 10.1097/MPG.0000000000001727. J Pediatr Gastroenterol Nutr. 2018. PMID: 28837505
European Epidemiology of Pleural Mesothelioma-Real-Life Data From a Joint Analysis of the Mesoscape Database of the European Thoracic Oncology Platform and the European Society of Thoracic Surgery Mesothelioma Database.
Opitz I, Bille A, Dafni U, Nackaerts K, Ampollini L, de Perrot M, Brcic L, Nadal E, Syrigos K, Gray SG, Aerts J, Curioni-Fontecedro A, Rüschoff JH, Monkhorst K, Weynand B, Silini EM, Bavaghar-Zaeimi F, Jakopovic M, Llatjos R, Tsimpoukis S, Finn SP, von der Thüsen J, Marti N, Dimopoulou G, Kammler R, Peters S, Stahel RA, Falcoz PE, Brunelli A, Baas P; ETOP Mesoscape and ESTS Consortia. Opitz I, et al. Among authors: silini em. J Thorac Oncol. 2023 Sep;18(9):1233-1247. doi: 10.1016/j.jtho.2023.06.011. Epub 2023 Jun 23. J Thorac Oncol. 2023. PMID: 37356802
Notch-Jagged1 signaling and response to bevacizumab therapy in advanced colorectal cancer: A glance to radiomics or back to physiopathology?
Negri F, Bottarelli L, Pedrazzi G, Maddalo M, Leo L, Milanese G, Sala R, Lecchini M, Campanini N, Bozzetti C, Zavani A, Di Rienzo G, Azzoni C, Silini EM, Sverzellati N, Gaiani F, De' Angelis GL, Gnetti L. Negri F, et al. Among authors: silini em. Front Oncol. 2023 Feb 28;13:1132564. doi: 10.3389/fonc.2023.1132564. eCollection 2023. Front Oncol. 2023. PMID: 36925919 Free PMC article.
Lymph node staging with 68Ga-PSMA PET in patients with intermediate and high-risk prostate cancer suitable for radical prostatectomy managed in a prostate cancer unit.
Maestroni UV, Campobasso D, Guarino G, Acampora A, Scarlattei M, Ziglioli F, Dinale F, Baldari G, Migliari S, Gasparro D, Ferretti S, Silini EM, Ruffini L. Maestroni UV, et al. Among authors: silini em. Chin Clin Oncol. 2023 Jun;12(3):22. doi: 10.21037/cco-23-10. Chin Clin Oncol. 2023. PMID: 37417288 Free article.
116 results